Literature DB >> 10090192

Smallest detectable difference in radiological progression.

M Lassere1, M Boers, D van der Heijde, A Boonen, J Edmonds, A Saudan, A C Verhoeven.   

Abstract

Omeract IV started a discussion on the development of radiological response criteria in rheumatoid arthritis (RA). Such criteria depend on the definition of what constitutes the minimum clinically important progression of damage. Because such a definition is currently not available, as a first step we have used the concept of random measurement error to determine what is the smallest detectable difference (SDD) in radiological progression between 2 radiographs of a particular patient. Baseline and 12 month radiographs (hands, wrists, feet) of 52 patients representative of the spectrum of radiological progression were selected from a randomized controlled trial of early rheumatoid arthritis (COBRA study) and were read paired and chronologically by 2 observers using the van der Heijde modified Sharp method (0-448 scale) and another 2 observers using the Scott modified Larsen method (0-200). The measurement error of progression was determined using the metric 95% limits of agreement method of Bland and Altman. In the setting of early RA the SDD is 11 modified Sharp score units and 8 modified Larsen score units if there is an equal distribution of baseline damage and progression in the sample and the mean score of the same trained observers is always used. The SDD is 15.5 modified Sharp score units and 11 modified Larsen score units if there is an equal distribution of baseline damage and progression in the sample and the mean score of any 2 trained observers is used. Other SDD were determined depending on the context of measurement. Although this exercise needs repetition in other settings, the SDD is a useful starting point in the development of radiological response criteria.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10090192

Source DB:  PubMed          Journal:  J Rheumatol        ISSN: 0315-162X            Impact factor:   4.666


  29 in total

Review 1.  Imaging: do erosions heal?

Authors:  D van der Heijde; R Landewé
Journal:  Ann Rheum Dis       Date:  2003-11       Impact factor: 19.103

2.  [Computer assisted radiological diagnostics of arthritic joint alterations].

Authors:  F Kainberger; G Langs; P Peloschek; T Schlager; C Schüller-Weidekamm; A Valentinitsch
Journal:  Z Rheumatol       Date:  2006-12       Impact factor: 1.372

Review 3.  [Quantitative imaging in rheumatoid arthritis: from scoring to measurement].

Authors:  P Peloschek; G Langs; A Valentinitsch; M Bubale; T Schlager; C Müller-Mang; F Kainberger
Journal:  Radiologe       Date:  2006-05       Impact factor: 0.635

4.  The Infliximab Multinational Psoriatic Arthritis Controlled Trial (IMPACT): results of radiographic analyses after 1 year.

Authors:  A Kavanaugh; C E Antoni; D Gladman; S Wassenberg; B Zhou; A Beutler; G Keenan; G Burmester; D E Furst; M H Weisman; J R Kalden; J Smolen; D van der Heijde
Journal:  Ann Rheum Dis       Date:  2006-01-26       Impact factor: 19.103

5.  Radiological damage in patients with rheumatoid arthritis on sustained remission.

Authors:  G Cohen; L Gossec; M Dougados; A Cantagrel; P Goupille; J P Daures; N Rincheval; B Combe
Journal:  Ann Rheum Dis       Date:  2006-08-25       Impact factor: 19.103

Review 6.  Prevention or retardation of joint damage in rheumatoid arthritis: issues of definition, evaluation and interpretation of plain radiographs.

Authors:  Maarten Boers; Désirée M F M van der Heijde
Journal:  Drugs       Date:  2002       Impact factor: 9.546

7.  Infliximab in active early rheumatoid arthritis.

Authors:  F C Breedveld; P Emery; E Keystone; K Patel; D E Furst; J R Kalden; E W St Clair; M Weisman; J Smolen; P E Lipsky; R N Maini
Journal:  Ann Rheum Dis       Date:  2004-02       Impact factor: 19.103

8.  Long term high intensity exercise and damage of small joints in rheumatoid arthritis.

Authors:  Z de Jong; M Munneke; A H Zwinderman; H M Kroon; K H Ronday; W F Lems; B A C Dijkmans; F C Breedveld; T P M Vliet Vlieland; J M W Hazes; T W J Huizinga
Journal:  Ann Rheum Dis       Date:  2004-11       Impact factor: 19.103

9.  Infliximab improves vascular stiffness in patients with rheumatoid arthritis.

Authors:  M Wong; S P Oakley; L Young; B Y Jiang; A Wierzbicki; G Panayi; P Chowienczyk; B Kirkham
Journal:  Ann Rheum Dis       Date:  2008-10-17       Impact factor: 19.103

10.  Impact of trough serum level on radiographic and clinical response to infliximab plus methotrexate in patients with rheumatoid arthritis: results from the RISING study.

Authors:  Tsutomu Takeuchi; Nobuyuki Miyasaka; Kazuhiko Inoue; Tohru Abe; Takao Koike
Journal:  Mod Rheumatol       Date:  2009-07-22       Impact factor: 3.023

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.